pyridinoline has been researched along with Inflammatory Bowel Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gamsjaeger, S; Klaushofer, K; Paschalis, EP; Srivastava, AK; Tatakis, DN; Wergedal, JE; Zwerina, J | 1 |
| Castro Laria, L; Herrerías Esteban, JM; Herrerías Gutiérrez, JM; Ledro Cano, D; Sáenz Dana, M; Torres Domínguez, Y | 1 |
2 other study(ies) available for pyridinoline and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Altered bone material properties in HLA-B27 rats include reduced mineral to matrix ratio and altered collagen cross-links.
Topics: Alveolar Bone Loss; Amino Acids; Animals; Bone Density; Glycation End Products, Advanced; HLA-B27 Antigen; Humans; Inflammatory Bowel Diseases; Osteoporosis; Rats; Rats, Transgenic | 2014 |
Biochemical markers and bone densitometry in inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Adult; Amino Acids; Biomarkers; Bone Density; Colitis, Ulcerative; Crohn Disease; Female; Follow-Up Studies; Humans; Inflammatory Bowel Diseases; Male; Osteocalcin | 2000 |